IP Library Granted Patent US 8,519,122
Granted Patent B2
US 8,519,122 · App. 13/024,908 · Granted Aug 27, 2013

Compositions and methods for modification of biomolecules

Inventors: John C. Jewett (Berkeley, CA); Carolyn Ruth Bertozzi (Berkeley, CA); Ellen May Sletten (Berkeley, CA); Chelsea Gloria Gordon (Berkeley, CA)
Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,519,122
App. No.
13/024,908
Granted
Aug 27, 2013
Kind
B2
Abstract

Provided are modified cycloalkyne compounds; and methods of use of such compounds in modifying biomolecules. Embodiments include a cycloaddition reaction that can be carried out under physiological conditions. The cycloaddition reaction involves reacting a modified cycloalkyne with an azide moiety on a target biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provide for its application in vivo and in vitro.

Claims (31)

1. A compound of the formula:

wherein

X 1 -X 8 are each independently selected from carbon and nitrogen;

each L is a divalent moiety independently selected from alkylene, substituted alkylene, alkenylene, substituted alkenylene, alkynylene, substituted alkynylene, arylene, substituted arylene, cycloalkylene, substituted cycloalkylene, heteroarylene, substituted heteroarylene, heterocyclene, substituted heterocyclene, carboxamido, C 1 to C 7 acyloxy, urethanylene, sulfonyl, sulfonamido, —O—, —S—, —NH—, and substituted amino; wherein substituents of the substituted divalent moieties are selected from carboxy, amino, halo, hydroxy, nitro, cyano, trifluoromethyl, C 1 to C 7 alkyl, C 1 to C 7 alkoxy, C 1 to C 7 acyloxy, carboxamide, carboxymethyl, and hydroxymethyl; and wherein the substituted and unsubstituted heteroarylene and heterocyclene divalent moieties are five or six-membered rings having 1 to 4 heteroatoms independently selected from oxygen, nitrogen and sulfur ring atoms;

each n is a number independently selected from zero to 40; and

Y 1 -Y 3 are independently selected from H; a group selected from a carboxyl, an amino, an alkoxycarbonyl, a RSC(O)—, a sulfonyl halide, a hydroxyl, an alkoxy, an —SH, an N-succinimidyl ester, an isothiocyanate, an iodoacetamide, a maleimidyl, a hydrazinyl, a hydrazide, a halogen, a cyano, a diazo, an azide, a guanidinyl, a sulfone, an epoxide, a diazirine, an alkenyl, an alkynyl, a phosphine, a silane and an alkylsulfonic acid; and a molecule of interest selected from a detectable label, a toxin, a peptide, a drug, a member of a specific binding pair, an epitope tag and a strained azacycloalkynone group.

2. The compound of claim 1 , wherein the compound is of formula III:

wherein

each L is a divalent moiety independently selected from alkylene, substituted alkylene, alkenylene, substituted alkenylene, alkynylene, substituted alkynylene, arylene, substituted arylene, cycloalkylene, substituted cycloalkylene, heteroarylene, substituted heteroarylene, heterocyclene, substituted heterocyclene, carboxamido, C 1 to C 7 acyloxy, urethanylene, sulfonyl, sulfonamido, —O—, —S—, —NH—, and substituted amino; wherein substituents of the substituted divalent moieties are selected from carboxy, amino, halo, hydroxy, nitro, cyano, trifluoromethyl, C 1 to C 7 alkyl, C 1 to C 7 alkoxy, C 1 to C 7 acyloxy, carboxamide, carboxymethyl, and hydroxymethyl; and wherein the substituted and unsubstituted heteroarylene and heterocyclene divalent moieties are five or six-membered rings having 1 to 4 heteroatoms independently selected from oxygen, nitrogen and sulfur ring atoms;

n is a number selected from zero to 40;

each R is independently selected from alkyl, substituted alkyl, alkoxy, substituted alkoxy, acylamino, acyloxy, amino, substituted amino, aminoacyl, aminoacyloxy, oxyaminoacyl, azido, cyano, halogen, hydroxyl, carboxyl, carboxylalkyl, —SH, aryl, aryloxy, hydroxyamino, alkoxyamino, nitro, —SO-alkyl, —SO-substituted alkyl, —SO-aryl, —SO-heteroaryl, —SO 2 -alkyl, —SO 2 -substituted alkyl, —SO 2 -aryl and —SO 2 -heteroaryl; wherein substituents are selected from carboxy, amino, halo, hydroxy, nitro, cyano, trifluoromethyl, C 1 to C 7 alkyl, C 1 to C 7 alkoxy, C 1 to C 7 acyloxy, carboxamide, carboxymethyl, and hydroxymethyl;

each a is a number selected from zero to four; and

Y is H; a group selected from a carboxyl, an amino, an alkoxycarbonyl, a RSC(O)—, a sulfonyl halide, a hydroxyl, an alkoxyl, an —SH, an N-succinimidyl ester, an isothiocyanate, an iodoacetamide, a maleimidyl, a hydrazinyl, a hydrazide, an aldehyde, a haloalkyl, a halogen, a cyano, a diazo, an azide, a guanidinyl, a sulfone, an epoxide, a diazirine, an alkenyl, an alkynyl, a phosphine, a silane, and an alkylsulfonic acid; or a molecule of interest selected from a detectable label, a toxin, a peptide, a drug, a member of a specific binding pair, an epitope tag and a strained azacycloalkynone group.

3. The compound of claim 2 , wherein the compound is of the formula:

wherein R is selected from hydrogen, alkyl, sulfonate, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, cycloalkyl, substituted cycloalkyl, heteroaryl, substituted heteroaryl, heterocyclyl, substituted heterocyclyl, sulfonyl, sulfonamide, amino and substituted amino; wherein the substituted and unsubstituted heteroaryl and heterocyclyl are five or six-membered rings having 1 to 4 heteroatoms independently selected from oxygen, nitrogen and sulfur ring atoms; and wherein substituents are selected from carboxy, amino, halo, hydroxy, nitro, cyano, trifluoromethyl, C 1 to C 7 alkyl, C 1 to C 7 alkoxy, C 1 to C 7 acyloxy, carboxamide, carboxymethyl, and hydroxymethyl.

4. The compound of claim 2 , wherein the compound is of formula V:

wherein each L is a divalent moiety independently selected from alkylene, alkenylene, alkynylene, arylene, cycloalkylene, heteroarylene, heterocyclene, acylamino, C 1 to C 7 acyloxy, urethanylene, sulfonyl, sulfonamido, —O—, —S—, and —NH—, and wherein the heteroarylene and heterocyclene divalent moieties are five or six-membered rings having 1 to 4 heteroatoms independently selected from oxygen, nitrogen and sulfur ring atoms;

n is a number selected from zero to 40; and

Y is H; a group selected from a carboxyl, an amino, an alkoxycarbonyl, a RSC(O)—, a sulfonyl halide, a hydroxyl, an —SH, an N-succinimidyl ester, an isothiocyanate, an iodoacetamide, a maleimidyl, a hydrazinyl, a hydrazide, an aldehyde, a haloalkyl, a halogen, a cyano, a diazo, an azide, a guanidinyl, a sulfone, an epoxide, a diazirine, an alkenyl, an alkynyl, a phosphine, a silane, and an alkylsulfonic acid; or a molecule of interest selected from a detectable label, a peptide, a member of a specific binding pair and an epitope tag.

5. The compound of claim 2 , wherein the compound is of formula VI:

wherein:

each L is a divalent moiety independently selected from alkylene, substituted alkylene, alkenylene, substituted alkenylene, alkynylene, substituted alkynylene, arylene, substituted arylene, cycloalkylene, substituted cycloalkylene, heteroarylene, substituted heteroarylene, heterocyclene, substituted heterocyclene, carboxamido, C 1 to C 7 acyloxy, urethanylene, sulfonyl, sulfonamido, —O—, —S—, —NH—, and substituted amino; wherein substituents of the substituted divalent moieties are selected from carboxy, amino, halo, hydroxy, nitro, cyano, trifluoromethyl, C 1 to C 7 alkyl, C 1 to C 7 alkoxy, C 1 to C 7 acyloxy, carboxamide, carboxymethyl, and hydroxymethyl; and wherein the substituted and unsubstituted heteroarylene and heterocyclene divalent moieties are five or six-membered rings having 1 to 4 heteroatoms independently selected from oxygen, nitrogen and sulfur ring atoms;

n is a number selected from zero to 40;

each R is independently selected from alkyl, substituted alkyl, alkoxy, substituted alkoxy, acylamino, acyloxy, amino, substituted amino, aminoacyl, aminoacyloxy, oxyaminoacyl, azido, cyano, halogen, hydroxyl, carboxyl, carboxylalkyl, —SH, aryl, aryloxy, hydroxyamino, alkoxyamino, nitro, —SO-alkyl, —SO-substituted alkyl, —SO-aryl, —SO-heteroaryl, —SO 2 -alkyl, —SO 2 -substituted alkyl, —SO 2 -aryl, —SO 2 -heteroaryl; wherein substituents are selected from carboxy, amino, halo, hydroxy, nitro, cyano, trifluoromethyl, C 1 to C 7 alkyl, C 1 to C 7 alkoxy, C 1 to C 7 acyloxy, carboxamide, carboxymethyl, and hydroxymethyl; and

each a is a number selected from zero to four.

6. The compound of claim 4 , wherein the compound is of one of the following structures:

7. The compound of claim 2 , wherein the compound is of one of the following structures:

8. The compound of claim 4 , wherein:

each L is a divalent moiety independently selected from alkylene, arylene, cycloalkylene, heteroarylene, heterocyclene, C 1 to C 7 acyloxy, acylamino, urethanylene, sulfonyl, sulfonamido, —O—, —S—, and —NH—, and wherein the heteroarylene and heterocyclene divalent moieties are five or six-membered rings having 1 to 4 heteroatoms independently selected from oxygen, nitrogen and sulfur ring atoms;

n is a number selected from zero to 40; and

Y is selected from H, a carboxyl, an amino, a hydroxyl, an alkoxycarbonyl, an N-succinimidyl ester, a RSC(O)—, an isothiocyanate, an iodoacetamide, a maleimidyl, a hydrazinyl, a hydrazide, a halogen, an epoxide, a fluorophore, an epitope tag, and a biotin.

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 8, 2011
From: UNIVERSITY OF CALIFORNIA BERKELEY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027195/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2011
From: JEWETT, JOHN C.; BERTOZZI, CAROLYN RUTH; SLETTEN, ELLEN MAY; GORDON, CHELSEA GLORIA
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 026244/0799 →
Continuity (2)
Provisional Application 61304208 · Feb 12, 2010
Related Publication 20110207147A1 · Aug 25, 2011